Business Wire

BLUE-PLANET

8.9.2020 14:35:11 CEST | Business Wire | Press release

Share
Blue Planet Science Fiction Film Festival Highlighted at the 77th Venice Film Festival

China’s Blue Planet Science-Fiction Film Festival was highlighted at the 77th Venice International Film Festival during the “Focus on China” side event earlier this week, bringing a glimpse of the future to the world’s oldest film festival.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200908005606/en/

The Venice International Film Festival is one of the first major cultural events held in Europe since the outbreak of the COVID-19 pandemic. The fact that the festival - one of the film industry’s most important annual events - could go ahead offline as planned is a major boost to a sector that has been hit hard by the pandemic. The “Focus on China” event was held in the National Pavilion of Italy and streamed online.

2019 was an international breakthrough year for Chinese sci-fi cinema. November 2019 saw the inaugural Blue Planet Sci-Fi Film Festival, the first of its kind in China. It recorded great success, with 185 sci-fi films from 17 countries screened and a series of activities such as forums, masterclasses and exhibitions held.

The second Blue Planet Sci-Fi Film Festival will be held in November 2020. In light of the difficult times our world is going through, the theme of this year’s festival will be “empathy”. “Amidst this global crisis, it is more important than ever for people around the world to transcend barriers and engage with each other,” said the Blue Planet Organizing Committee in a message to the event.

Industry figures at the Venice Film Festival noted a buzz around the development of Chinese sci-fi. Roberto Stabile, head of international relations for the Italian motion picture association ANICA, said, “I was very impressed by this introduction to the Blue Planet Sci-Fi Film Festival, and look forward to welcoming our friends from the Blue Planet in Venice next year.”

Italian-Chinese filmmaker Shi Yangshi said, “Two years ago, Italian director Giuseppe Tornatore talked to me about Liu Cixin’s sci-fi novels and showed great interest in co-producing sci-fi films with China.” Italian producer Luca Confortini remarked, “China has a well-established film culture and its sci-fi films have been developing rapidly. The Blue Planet is an important and vibrant film event; I believe that China’s sci-fi film market will only grow bigger.”

Six Chinese-directed sci-fi short films chosen from the first Blue Planet were screened during the Film Festival.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Xylem Announces Segment Leadership Appointments30.6.2026 13:30:00 CEST | Press release

Xylem Inc. (NYSE: XYL), a leading global water solutions company, today announced two executive leadership appointments, effective July 1, both reporting to President and Chief Executive Officer Matthew Pine. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630087773/en/ Meredith Emmerich has been appointed EVP and President, Measurement and Control Solutions at Xylem. Meredith Emmerich has been appointed EVP and President, Measurement and Control Solutions. Most recently, she served as EVP and President, Applied Water at Xylem. Emmerich joined Xylem in 2024 from Carrier Global Corporation (NYSE: CARR), where she was Vice President of Global Enterprise Solutions and held several senior leadership roles, including leading the Americas Commercial HVAC business and the Global Residential, Light Commercial, and VRF HVAC portfolio. Emmerich succeeds Mike McGann, who will serve as senior advisor to ensure a smooth and orderly tra

Strike Europe Secures Full MiCA Authorization, Unlocking Bitcoin Services Across All 27 EU Member States30.6.2026 13:29:00 CEST | Press release

Strike is now available to millions of customers across the European Union Strike, a leading Bitcoin financial services company, today announced that its European entity, Zap (Strike) Europe Limited, has been authorized as a crypto-asset service provider by the Malta Financial Services Authority (MFSA) under the EU's Markets in Crypto-Assets Regulation (MiCA) and the Malta Markets in Crypto Assets Act (Cap. 647, laws of Malta) to provide crypto-asset services. The license enables millions of Europeans across all 27 EU member states to access Strike's suite of Bitcoin financial services under a single regulatory framework, replacing the patchwork of national regimes that previously governed the market. Strike has served eligible European customers since April 2024. The MFSA authorization makes that presence permanent and EU-wide, and positions the company among a small group of firms to complete the MiCA process to date. "Europe deserves a Bitcoin-only company focused on doing one thing

OpZira, Inc. Welcomes Scott Thielman, PhD, as Vice President of Product Development30.6.2026 13:17:00 CEST | Press release

OpZira™, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced that Scott Thielman, PhD, PE, has joined the company as Vice President of Product Development, effective May 1, 2026. Dr. Thielman brings a unique connection to OpZira’s origins. As Chief Technology Officer of Product Creation Studio, he directed the product development of LumiThera’s Valeda® Light Delivery System - the breakthrough photobiomodulation therapy for dry age-related macular degeneration whose acquisition by Alcon led to the creation of OpZira. His involvement with Valeda gives him firsthand knowledge of the science, clinical vision, and engineering decisions that shaped the technology platform from which OpZira was born. For more than 25 years, Dr. Thielman has directed the development of dozens of FDA-cleared medical devices across ophthalmology, neurostimulation, dermatology, urology, and surgical instrumentation, with partners including Olympus

L&T Technology Services Launches Ainfonix™ 4.0 to Unlock Engineering Intelligence Across Process Industries30.6.2026 12:45:00 CEST | Press release

The enterprise AI platform turns millions of engineering artifacts that run a plant into accurate, decision-ready data, delivering up to 85% extraction accuracy and full, audit-ready traceability L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in Engineering Intelligence Solutions & ER&D Consulting Services, today announced the launch of Ainfonix™ 4.0, a next-generation Engineering Intelligence platform for process industries. Unveiled at EI Live, LTTS’ flagship event that brings together analysts, industry leaders and engineering experts, Ainfonix™ 4.0 marks an important step in the company’s Enterprise AI and Engineering Intelligence strategy. As industrial enterprises accelerate AI adoption, decades of engineering knowledge remain trapped in fragmented drawings, specifications and technical records across disparate systems. Without trusted and accessible engineering data, organizations struggle to realize the full value of AI, automation and digital transformation

Klick Health Acquires Oxford PharmaGenesis, Bringing Together Unsurpassed Scientific-to-Commercial Capabilities for Life Sciences Clients30.6.2026 12:03:00 CEST | Press release

Bonded by breakthroughs and a laser focus on their people and clients, leading independent agencies join forces to deliver accelerated commercial success through broadened medical affairs and communications, market access, and RWE/HEOR offerings; the most advanced degree holders; expanded global reach; and the best workplace culture around Focused on taking life sciences companies into the future, Klick Health today announced its acquisition of Oxford PharmaGenesis, the market-leading HealthScience communications consultancy renowned for its scientific and medical expertise, as well as value and market access consulting throughout Europe, Asia-Pacific, and North America. Today’s news brings together two of the leading independent agencies in life sciences. With Oxford PharmaGenesis’ expertise across medical affairs and market access, and Klick's strength in commercial strategy, medical, creative, digital, analytics, and experience design, they can deliver an unparalleled scientific-to-

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye